The Valley Desk

NCT04592341 · Interventional trial

A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Overall registry status Terminated

Phase 2

Conditions Alzheimer Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov